dc.contributor.author | Say, Bahar | |
dc.contributor.author | Ergun, Ufuk | |
dc.date.accessioned | 2020-06-25T18:34:28Z | |
dc.date.available | 2020-06-25T18:34:28Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Say B., Ergün U. (2019). Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?. Türk Nöroloji Dergisi, 25(3), 184 - 186. | en_US |
dc.identifier.issn | 1301-062X | |
dc.identifier.issn | 1309-2545 | |
dc.identifier.uri | https://doi.org/10.4274/tnd.galenos.2019.87513 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/7922 | |
dc.description | WOS: 000487283000017 | en_US |
dc.description.abstract | … | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Turkish Neurological Soc | en_US |
dc.relation.isversionof | 10.4274/tnd.galenos.2019.87513 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Ankylosing spondylitis | en_US |
dc.subject | multiple sclerosis | en_US |
dc.subject | TNF-alpha antagonist | en_US |
dc.subject | adalimumab | en_US |
dc.title | Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental? | en_US |
dc.type | letter | en_US |
dc.contributor.department | Kırıkkale Üniversitesi | en_US |
dc.identifier.volume | 25 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 184 | en_US |
dc.identifier.endpage | 186 | en_US |
dc.relation.journal | Turkish Journal Of Neurology | en_US |
dc.relation.publicationcategory | Diğer | en_US |